Researchers compared COVID-19 outcomes in rheumatoid arthritis patients treated with biologic vs conventional DMARDs.
MedPage Today on MSN
Difficult-to-Treat Rheumatoid Arthritis: Is Prevention Feasible?
CHICAGO -- Hitting rheumatoid arthritis (RA) early and hard, with targeted therapies as first-line treatment, appears to ...
New research presented at ACR 2025 shows GLP-1 receptor agonists, used for diabetes and obesity, may reduce rheumatoid ...
Several factors — but not older age — increased infection risk with the use of non-TNF biologics following first-line ...
Health care resource use increased in patients with Sjögren disease during the year after diagnosis, especially among those with comorbid autoimmune disorders.
An observational cohort study uses multi-omics profiling to identify distinct biomarkers that could aid in the earlier ...
Sustained improvements across stringent measures of disease in patients with psoriatic arthritis (PsA): One-year improvements were sustained to three years across strict measures of peripheral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback